How COVID is reshaping global policy and what it means for market access

The COVID-19 pandemic has upended daily lives around the globe and has also created new challenges for life sciences companies and governments alike in their mission to ensure effective treatments are both developed and available to patients in need. At a time of uncertainty, governments around the world have instituted policy changes intended to mitigate the impact of the coronavirus that could have long-lasting impacts for the global health sector.

As the pandemic extends, our global market access experts identified five major themes affecting markets in six continents that will influence how effectively the global response to the pandemic will be and implications for non-coronavirus treatments as well. These include: